ArticlemedRxiv : the preprint server for health sciences2026
Multimodal evidence for a mechanistic model of working memory deficits in schizophrenia.
Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Working memory (WM) deficits are central to schizophrenia (SCZ), yet their mechanistic basis remains unclear. We combined computational modelling with genetic, transcriptomic, behavioural, and fMRI data to construct a mechanistic account of WM impairment in SCZ. Post-mortem RNA expression from prefrontal and anterior cingulate cortex (ACC) was integrated with single-cell, network, and synaptic plasticity models to show how SCZ-related changes in ion channel-encoding and plasticity-regulating genes alter sustained delay-period activity and long-term potentiation, suggesting an impairment of WM. The model predictions were supported by behavioural WM test (letter-number sequencing) results and polygenic risk scores for SCZ based on ion channel and plasticity gene sets. Mendelian randomization, together with nominally significant single-gene risk analyses, implicated specific ion channel genes, particularly CACNA1I, as putatively causal for both SCZ liability and WM deficits. fMRI N-back data supported ACC-specific delay-period impairments. These multimodal findings highlight candidate, druggable mechanisms for cognition-focused interventions in SCZ.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.